EHRA Premium Access

Which is the benefit of ICD in patients with ischemic cardiomyopathy compare with those with idiopathic dilated cardiomyopathy, from DANISH trial to real life.

Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)

Congress Presentation

About the speaker

Doctor Alejo Tronconi

Favaloro Foundation University Hospital, Buenos Aires (Argentina)
0 follower

13 more presentations in this session

Validation of a madit-ii derived, primary prevention mortality risk score after implantable cardioverter-defibrillator implantation

Speaker: Doctor J. Acosta Martinez (Seville, ES)


Clinical outcomes after implantable cardioverter-defibrillator implantation: does gender matter? a propensity score analysis

Speaker: Doctor J. Acosta Martinez (Seville, ES)


Are implantable defibrillators less useful in patients with non-ischemic heart disease?

Speaker: Doctor A. Marinheiro (Setubal, PT)


Survival analysis in patients with and without implantable cardioverter defibrillator for primary prevention indication: a single-centre multiethnic experience

Speaker: Miss A. Ayemon (Southampton, GB)


Postextrasystolic blood pressure potentiation is associated with appropriate device therapy and mortality in implantable cardioverter defibrillator recipients with a reduced LVEF

Speaker: Miss A. van der Lingen (Amsterdam, NL)


Access the full session

Poster session 1 - Sudden cardiac death and implantable defibrillators

Speakers: Doctor A. Tronconi, Doctor J. Acosta Martinez, Doctor J. Acosta Martinez, Doctor A. Marinheiro, Miss A. Ayemon...

About the event



18 June - 21 June 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb